[Clinical experiences on the anti-dyslipidemic effect of a new sulfomucopolysaccharide of pancreatic origin].
D000328:Adult; D000368:Aged; D001161:Arteriosclerosis / Q000188:drug therapy*; D003327:Coronary Disease / Q000188:drug therapy; D005260:Female; D006025:Glycosaminoglycans / Q000627:therapeutic use*; D006801:Humans; D006937:Hypercholesterolemia / Q000188:drug therapy; D006949:Hyperlipidemias / Q000188:drug therapy*; D002537:Intracranial Arteriosclerosis / Q000188:drug therapy; D050356:Lipid Metabolism; D008297:Male; D008875:Middle Aged; D010184:Pancreatic Extracts / Q000627:therapeutic use*
D006025:Glycosaminoglycans; D010184:Pancreatic Extracts
Esperienze cliniche sull'effetto antidislipidemico di un nuovo solfomucopolisaccaride di origine pancreatica.